State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510182, China.
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510182, China; Guangzhou Laboratory, Bio-Island, Guangzhou, Guangdong 510320, China.
Curr Opin Virol. 2022 Feb;52:102-111. doi: 10.1016/j.coviro.2021.11.015. Epub 2021 Dec 11.
Human respiratory coronaviruses (HCoVs), including the recently emerged SARS-CoV-2, the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, potentially cause severe lung infections and multiple organ damages, emphasizing the urgent need for antiviral therapeutics and vaccines against HCoVs. Small animal models, especially mice, are ideal tools for deciphering the pathogenesis of HCoV infections as well as virus-induced immune responses, which is critical for antiviral drug development and vaccine design. In this review, we focus on the antiviral innate immune response, antibody response and T cell response in HCoV infected mouse models, and discuss the potential implications for understanding the anti-HCoV immunity and fighting the COVID-19 pandemic.
人类呼吸道冠状病毒(HCoVs),包括最近出现的严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2),是导致 2019 冠状病毒病(COVID-19)大流行的病原体,可能导致严重的肺部感染和多器官损伤,这强调了急需针对 HCoVs 的抗病毒治疗药物和疫苗。小动物模型,特别是小鼠,是解析 HCoV 感染发病机制以及病毒诱导免疫反应的理想工具,这对于抗病毒药物开发和疫苗设计至关重要。在本综述中,我们重点讨论了 HCoV 感染小鼠模型中的抗病毒先天免疫反应、抗体反应和 T 细胞反应,并讨论了这些反应对于理解抗 HCoV 免疫和应对 COVID-19 大流行的潜在意义。